DKK1 Suppresses Hippo Signaling via PIP 3 –OGT–LRP6 O -GlcNAcylation in Hepatocellular Carcinoma
Cancer Communications · 01.01.2026 · 46
DOI: 10.34133/cancomm.0022 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cancer Communications, online erschienen am 27.04.2026. Verfasst von Ukjin Lee und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science, University of Seoul, Seoul 02504, Republic of Korea. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
T1466 is required for LRP6-mediated suppression of Hippo pathway activity. Hippo pathway was evaluated by Western blotting in cells overexpressing LRP6 WT or alanine-substitution mutants at the putative O -GlcNAcylation sites
Autor:innen und Institutionen
- Department of Life Science, University of Seoul, Seoul 02504, Republic of Korea.
- Department of Gastroenterology, Ajou University School of Medicine, Suwon 16499, Republic of Korea.
- Department of Molecular Medicine and Biopharmaceutical Sciences, Seoul National University, Seoul 03080, Republic of Korea.
- Department of Bioinformatics, Soongsil University, Seoul 06978, Republic of Korea.
- Division of Molecular Embryology, Center for Molecular Biology of Heidelberg University-German Cancer Research Center Alliance, Heidelberg 69120, Germany.
- Department of Chemistry, Sungkyunkwan University, Suwon 16419, Republic of Korea.
ORCID-Profile: Eek-Hoon Jho
Förderung
- National Research Foundation of Korea
Zitieren
APA
Lee, U., Eun, J. W., Kim, T., Shim, H., Choi, Y., Jung, H., Mo, J., Kim, S. S., Baek, G. O., Yoon, M. G., Lee, H., Lee, W., Kim, W., Kim, J., Yi, E. C., Kim, S. U., Cheong, J. Y., & Jho, E. H. (2026). DKK1 Suppresses Hippo Signaling via PIP 3 –OGT–LRP6 O -GlcNAcylation in Hepatocellular Carcinoma. Cancer Communications, 46. https://doi.org/10.34133/cancomm.0022
Vancouver
Lee U, Eun JW, Kim T, Shim H, Choi Y, Jung H, et al. DKK1 Suppresses Hippo Signaling via PIP 3 –OGT–LRP6 O -GlcNAcylation in Hepatocellular Carcinoma. Cancer Communications. 2026;46. doi:10.34133/cancomm.0022
BibTeX
@article{Lee2026,
author = {Lee, Ukjin and Eun, Jung Woo and Kim, Taehee and Shim, Hyewon and Choi, Yunho and Jung, Hyeryeon and Mo, Jaewoo and Kim, Soon Sun and Baek, Geum Ok and Yoon, Moon Gyeong and Lee, Hyeyoon and Lee, Wonhwa and Kim, Wantae and Kim, Junil and Yi, Eugene C and Kim, Seung Up and Cheong, Jae Youn and Jho, Eek-Hoon},
title = {DKK1 Suppresses Hippo Signaling via PIP 3 –OGT–LRP6 O -GlcNAcylation in Hepatocellular Carcinoma},
journal = {Cancer Communications},
year = {2026},
volume = {46},
doi = {10.34133/cancomm.0022}
}
EUVIMED